Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome

Summary

A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables. Burning mouth syndrome (BMS) is defined as an oral burning sensation in the absence of clinical signs which could justify the syndrome. Recent studies suggest the existence of neurological factors as a possible cause of the disease.

Timeline

Start

2020-01-20

Primary completion

2023-05-25

Completion

2023-05-30

Drugs

Indications